Cardiology Grand Rounds Archives

Since our founding by Dr. Denton A. Cooley in 1962, THI has remained dedicated to improving the standard of care through education and research. To enhance the didactic learning experience of our local, national and global network, Cardiology Grand Rounds presentations are recorded and offered as non-CME accredited, enduring education through the THI Library & Learning Resource Center and online in the Grand Rounds Archives. Visit our Grand Rounds Photo Gallery

Cell Therapy for Heart Failure: Are We There Yet?

THI Medical Director, Emerson Perin, MD, PhD, has built an internationally recognized preclinical and clinical stem cell research program and has contributed to important discoveries and advancements in interventional cardiology.

Clyde W. Yancy | Heart Failure in 2020: Addressing the Unanswered Questions

Clyde W. Yancy, MD

Victor Pretorius | Pulmonary Thromboendarterectomy Surgery for CTEPH

Victor Pretorius, MD

Quantitative Coronary Flow Capacity by PET: An Imaging Biomarker of Cardiovascular Risk

Nishant R. Shah, MD, MPH, MSc

RV Pacing: An Ancient History. An Introduction to HIS Bundle Pacing

Parik Sharma, MD, MPH

Hypertrophic Cardiomyopathy: Current Perspectives

John Lynn Jefferies, MD, MPH, FAAP, FACC, FAHA, FHFSA

CCTA and FFRct for stable angina- lessons learned and future opportunities and challenges.

Jonathan Leipsic, MD

Chronic venous insufficiency: The forgotten part of circulation

Zvonimir Krajcer, MD

Non-compaction left ventricle: a comprehensive update

Paolo Angelini, MD

All is in Flux: Journeys in Cardiac Metabolism

Heinrich Taegtmeyer, MD

Innovations in Clinical Care: A Clinicians Role

Dr. Mehdi Razavi provides a historical view of devices and techniques used to detect, manage and treat various cardiac arrhythmias today and reviews the current state of translational and clinical research while highlighting the next generation of innovative heart rhythm devices aimed to improve outcomes and quality of life.

CV Effects of Diabetes Medications: Lessons Learned from the Cardiovascular Outcome Trials

Dr. Darren McGuire reviews the evolution of the regulatory requirements for
 drugs for type 2 diabetes, the key findings from CV outcome trials completed to date and selected potential mechanisms underpinning beneficial effects of SGLT2 inhibitors on CV mortality and heart failure risk.

Renovations in the house of medicine: Past, present, and future

Joseph Hill, MD, PhD is the James T. Willerson, M.D. Distinguished Chair in Cardiovascular Diseases at the University of Texas Southwestern Medical Center. He is a distinguished cardiologist-scientist and presently serves as the Editor-in-Chief of Circulation.



Updates on Non-Compaction Left Ventricle: a newly discovered entity in search for an identity

Paolo E. Angelini, MD